Catalase-Loaded Silica Nanoparticles Formulated via Direct Surface Modification as Potential Oxygen Generators for Hypoxia Relief
Authors:
- 26 January 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (5) , 5945-5954
Abstract
Enzymes are biological catalysts that have many potential industrial and biomedical applications. However, the widespread use of enzymes in the industry has been limited by their instability and poor recovery. In biomedical applications, systemic administration of enzymes has faced two main challenges: limited bioactivity mostly due to rapid degradation by proteases and immunogenic activity, since most enzymes are from nonhuman sources. Herein, we propose a robust enzyme-encapsulation strategy to mitigate these limitations. Catalase (CAT) was encapsulated in nanoporous silica nanoparticles (CAT-SiNPs) by first chemically modifying the enzyme surface with a silica precursor, followed by silica growth and finally poly(ethylene glycol) (PEG) conjugation. The formulation was carried out in mild aqueous conditions and yielded nanoparticles (NPs) with a mean diameter of 230 ± 10 nm and a concentration of 1.3 ± 0.8 × 1012 NPs/mL. CAT-SiNPs demonstrated high enzyme activity, optimal protection from proteolysis by proteinase K and trypsin, and excellent stability over time. In addition, a new electrochemical assay was developed to measure CAT activity in a rapid, simple, and accurate manner without interference from chromophore usually present in biological samples. Concentrations of 2.5 × 1010 to 80 × 1010 CAT-SiNPs/mL not only proved to be nontoxic in cell cultures using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay but also conferred cell protection when cells were exposed to 1 mM hydrogen peroxide (H2O2). Finally, the ability of CAT-SiNPs to release oxygen (O2) when exposed to H2O2 was demonstrated in vivo using a rat model. Following the direct injection of CAT-SiNPs in the left kidney, partial pressure of oxygen (pO2) increased by more than 30 mmHg compared to the contralateral control kidney during the systemic infusion of safe levels of H2O2. This pilot study highlights the potential of CAT-SiNPs to generate O2 to relieve hypoxia in tissues and potentially sensitize tumors against radiation therapy.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP190233, RR150010)
- American Cancer Society (ACS-IRG-17-174-13)
- National Science Foundation
- Children's Cancer Fund Comprehensive Center for Pediatric Oncology Research
This publication has 66 references indexed in Scilit:
- Industrial applications of enzyme biocatalysis: Current status and future aspectsBiotechnology Advances, 2015
- Allergic reactions and antiasparaginase antibodies in children with high‐risk acute lymphoblastic leukemia: A children's oncology group reportCancer, 2015
- Biocatalysis in Organic Chemistry and Biotechnology: Past, Present, and FutureJournal of the American Chemical Society, 2013
- Bioinspired enzyme encapsulation for biocatalysisTrends in Biotechnology, 2008
- Enzyme Immobilization: The Quest for Optimum PerformanceAdvanced Synthesis & Catalysis, 2007
- Methionine dependency and cancer treatmentCancer Treatment Reviews, 2003
- The enzyme as drug: application of enzymes as pharmaceuticalsCurrent Opinion in Biotechnology, 2003
- Industrial enzyme applicationsCurrent Opinion in Biotechnology, 2002
- Industrial biocatalysis today and tomorrowNature, 2001
- L-Asparaginase Therapy for Leukemia and Other Malignant NeoplasmsJAMA, 1967